Tag: orphan drug incentives
Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits would otherwise be impossible. It’s not a patent-but it’s just as powerful.
View More
